Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Theophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics

1 Jan 1999

Abstract excerpt

Nebulized recombinant human deoxyribonuclease (DNase) reduces sputum viscosity and improves lung function in some cystic fibrosis patients, but individual responses are unpredictable. The aim of this study was to investigate how DNase can be targeted to those cystic fibrosis patients who would benefit most. The Scottish Cystic Fibrosis Group agreed on a randomized, double-blind, placebo-controlled n-of-1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis Research Advances
Share to Tracheal and airway disorders

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 10836333
DOI: 10.1183/09031936.99.13105399

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Theophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmaticsPMID 10836333Read ↗

Safety and Efficacy of Recombinant Alpha1-Antitrypsin Therapy in Cystic FibrosisSemantic proximity Read ↗

Improved Potency of Hyperactive and Actin-resistant Human DNase I Variants for Treatment of Cystic Fibrosis and Systemic Lupus ErythematosusSemantic proximity Read ↗

Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator ReconstitutionSemantic proximity Read ↗

Prospective randomised unblinded comparison of sputum viscosity for three methods of saline nebulisation in mechanically ventilated patients: a study protocolSemantic proximity Read ↗

Outcome measures for cystic fibrosis gene therapy clinical trialsSemantic proximity Read ↗

Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung DiseaseSemantic proximity Read ↗

Long-term use of nebulized human recombinant DNase1 in two siblings with primary ciliary dyskinesiaSemantic proximity Read ↗

Interleukin-8 in whole blood and clinical status in cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.